MiMedx Group Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, and thank you for joining us today on the third day of the JPMorgan Healthcare Conference. My name is Caroline Borowski, and I'm a team member here at the JPMorgan team. It is my honor and pleasure to introduce you to Tim Wright, our CEO; and Pete Carlson, our CFO of MiMedx.
Thank you, Caroline, and I want to thank JPMorgan for the invitation to present here. First of all, I'd like to move quickly to the next slide. Everyone can take a look at our disclaimers here. Just please take note of the disclaimers and the cautionary statement. Obviously, it's a fairly raw thing for us to be doing. But there are forward-looking statements in here, I want you to be aware of that.
Let's move to the next slide. MiMedx has been through a transformative year. And next year or 2022 will be an equally transformative year. MiMedx is a placental biologics company that has the capacity to transform medicine in certain indications. And also at the same time, this company has been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
